Russia’s personalised mRNA cancer vaccine shows early success

Russia has made a breakthrough in cancer and autoimmune disease treatment by developing a personalised mRNA vaccine. Early clinical use on a melanoma patient shows promise. If successful in further trials, the vaccine could expand to other cancers and be included in national health programs, offering affordable, effective treatment globally.